Latest Stock Market News

Promoters held 10.15 per cent stake in the company as of 31-Mar-2023, while FII and DII ownership stood at 47.71 per cent and 29.78 per cent, respectively.

The stock traded at a P/E multiple of 10.1, while the price-to-book value ratio stood at 1.06.

I would say that both these stocks can give you moderate returns from here, but definitely the momentum currently seems to be more in favour of ITC than HUL.

The Nifty IT index was trading 0.16 per cent up at 27056.7.

While foreign brokerage Jefferies has maintained a ‘buy’ rating on the Lodha Group company estimating a 35% upside, domestic brokerage HDFC Securities has left the price unchanged. Meanwhile, ICICI Securities has slashed the target price while cautioning for headwinds. Should you buy, sell or hold this stock?

The stock quoted a 52-week high of Rs 1509.25 and a 52-week low of Rs 1047.7.

Cyient shares have gained nearly 10% in the last three trading sessions. The rally was also on the back of strong Q4 earnings posted by the company on April 20, Thursday. The uptrend is likely to sustain going ahead, aided by strong technicals.

​So I think Crompton has got de-rated in the last 12 to 15 months and now this management change which is happening, I think needs to look at in a very different manner because this is a board driven company and there is no promoter of the company per se.

Ipca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 18871.79 Crore) operating in Pharmaceuticals sector.

The Nifty Realty index closed 1.06 per cent up at 428.0.